ProtoKinetix

ProtoKinetix Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of ProtoKinetix (PKTX) as of Nov 19, 2026 is -856.39. In the previous year, Cash Conversion Cycle (CCC) was -0.34 — a change of 253,207.33% (lower).

Cash Conversion Cycle

-856.39

YoY

253,207.33%

Last updated:

Cash Conversion Cycle (CCC) of ProtoKinetix is 2024 -856.39 . Cash Conversion Cycle (CCC) of ProtoKinetix was 2023 -0.34 . It decreases by 253,207.33% lower compared to the previous year.

The ProtoKinetix Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2017
-3,273.56 USD
Jan 1, 2018
-9,597.68 USD
Jan 1, 2019
-3.10 USD
Jan 1, 2020
-5.47 USD
Jan 1, 2021
-11.35 USD
Jan 1, 2022
-0.26 USD
Jan 1, 2023
-0.34 USD
Jan 1, 2024
-856.39 USD
The ProtoKinetix Cash Conversion Cycle history
YEARCash Conversion CycleYoY
-856.39+253,207.33%
-0.34+30.36%
-0.26-97.71%
-11.35+107.45%
-5.47+76.18%
-3.10-99.97%
-9,597.68+193.19%
-3,273.56-40.49%
-5,501.04-49.83%
-10,964.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProtoKinetix Stock analysis

What does ProtoKinetix do? ProtoKinetix Inc. is a Canadian biotechnology company focused on the development of glycoproteins for therapeutic applications. The company was founded in 2005 and is headquartered in Marietta, USA. ProtoKinetix specializes in the research and development of AAGP® (Anti-Aging Glycopeptide) as biopharmaceuticals. These proprietary glycoproteins have the ability to protect cells and can be used in various therapeutic applications for improving damage in physical injury, spinal cord injury, diabetes, transplantation, and retinal diseases. In addition to the medical field, ProtoKinetix is also developing its patented technology for use in bio-agriculture and animal healthcare. It has a subsidiary that holds the rights to use and distribute AAGP® and its patents. ProtoKinetix's business model involves licensing its glycoprotein technology for various applications, including biopharmaceuticals, bioprocessing industries, and cell protection management for regenerative medicine and stem cell preparations. The company has established partnerships with other biotech companies to integrate its AAGP® technology into their product pipelines. ProtoKinetix's flagship product is the AAGP® protein solution, which is used as a medication in regenerative medicine, organ transplantation, eye healing, and animal health. It is also interested in researching the application of AAGP® in crop farming to increase yields and improve soil quality. ProtoKinetix is poised to play a significant role in the development of glycoproteins as future medicines and therapeutic technologies in various industries. It not only has the potential to explore healing medical products but also aims to enhance agriculture and animal care. ProtoKinetix represents an excellent example of a biotechnology company focused on improving the healthcare and agricultural industries. ProtoKinetix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProtoKinetix stock

Cash Conversion Cycle (CCC) of ProtoKinetix is -856.39 in 2024.

Cash Conversion Cycle (CCC) of ProtoKinetix changed from -0.34 to -856.39, representing a 253,207.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) ProtoKinetix since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s ProtoKinetix with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ProtoKinetix

All Key Metrics — ProtoKinetix